The tweet was deleted by the author.
But we saved everything 🙂.
Bicara Therapeutics Inc. will release its financial results for the second quarter of 2026 and provide a business update on Tuesday, August 11.
The company will follow the announcement with a conference call scheduled for 8:30 AM ET the same day. Investors and stakeholders can register for the call and access the live webcast through the company's website.
View post on X Loading...
Earlier this year, Bicara Therapeutics appointed Jeremy Bender and Christy Oliger, both with extensive biopharma experience, to its board of directors. The new appointments expanded the company’s leadership team. The company continues to update investors through regular announcements and scheduled calls.